Aspira Women's Health (AWH) 10-Q2024 Q1 Quarterly report

Filed: 15 May 24, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AACR, AGP, alter, ARUP, asset, attention, attrition, Biology, burden, Canada, clause, CODM, complaint, concurrent, Conference, consortium, court, Dana, debilitating, dedicated, detachable, diagnosed, diverting, drawn, elevated, embody, endometrioma, entry, Farber, freezer, God, grandfather, handling, headcount, highlighted, important, incorrectly, inside, Investigation, investigational, IVDSM, joint, Kevin, kind, labeling, landscape, larger, life, majeure, manufactured, Markedly, metadata, modification, NOL, overturned, PCR, people, pipeline, poster, postmarket, principle, Professor, provision, recall, reevaluation, referral, Refresh, regularly, reintroduced, remeasured, removal, repeated, Reproductive, residual, revised, safety, segment, shelf, similarly, Simplification, SRI, storage, stratify, surveillance, thousand, timeline, triage, unchanged, Unmodified, Vancouver, variety, verification, workflow

Removed: accelerate, acceleration, accrue, accurately, Additionally, adequate, adjust, adjusted, announcement, asymptomatic, authorize, Axia, BBVA, behalf, biopsy, Black, Blair, calculation, calendar, CE, cohort, collateral, commencing, committed, commonly, comparable, conforming, consolidation, consultation, consummation, contractor, converted, core, corrected, COSO, cover, deficiency, degree, Description, detail, detect, detected, deteriorate, deterioration, difficult, directly, disposition, document, documented, duly, earlier, easier, effected, embedded, employee, eradicate, error, estimating, exchanged, Exhibit, expensed, Extension, external, fairly, false, focusing, found, fundamental, grew, guide, hand, Herewith, highest, hold, hormone, impacted, improvement, inadequate, incidentally, inclusion, incorporation, indexation, inform, inherent, Inline, Instance, instant, instruct, Integrated, integration, Interactive, invasive, irrevocably, issue, journey, largest, leading, letter, Linkbase, marked, materiality, merger, method, nation, nationally, negotiated, notifying, obligated, occurrence, OfferingSM, online, OVAWATCHSM, Page, partially, partnership, Paycheck, point, positioning, PPP, predictive, preferred, premature, prevented, prevention, privately, promulgated, proportion, proposal, Protection, quantitative, ratio, recognition, reduction, reference, regain, registrant, released, reliability, Relief, repay, retrospective, retrospectively, safely, Schema, sensitive, separate, sequentially, serial, Small, smaller, solution, supplementing, supportable, suspected, SynergySM, Taxonomy, thereunto, timelier, transform, Transition, Treadway, tumour, type, unauthorized, undersigned, understand, underwriter, underwritten, unexercised, unutilized, USA, utilizing, visualization, volatile, VWAP, waiver, William, XBRL

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated AWH transcripts

AWH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of the Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

with Respect to the Quarterly Report on Form 10-Q

for the Period Ended March 31, 2024

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Aspira Women’s Health Inc., a Delaware corporation (the “Company”), does hereby certify, to the best of such officer’s knowledge, that:

The Company’s quarterly report on Form 10-Q for the period ended March 31, 2024, (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

Information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 15, 2024	/s/ Nicole Sandford
	Nicole Sandford Chief Executive Officer (Duly Authorized Officer and Principal Executive Officer)

Date: May 15, 2024	/s/ Torsten Hombeck
	Torsten Hombeck Chief Financial Officer (Duly Authorized Officer, Principal Financial Officer and Principal Accounting Officer)

The certification set forth above is being furnished as an Exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Form 10-Q or as a separate disclosure document of the Company or the certifying officers.